Intrinsic Value of S&P & Nasdaq Contact Us

MapLight Therapeutics, Inc. MPLT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$31.00
+14.7%

MapLight Therapeutics, Inc. (MPLT) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Redwood City, CA, United States. The current CEO is Christopher A. Kroeger.

MPLT has IPO date of 2025-10-24, 109 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $21.33M.

About MapLight Therapeutics, Inc.

No company description available.

📍 800 Chesapeake Drive, Redwood City, CA 94063 📞 617 984 6300
Company Details
SectorHealthcare
IndustryBiotechnology
CountryUnited States
ExchangeNASDAQ Global Select
CurrencyUSD
IPO Date2025-10-24
CEOChristopher A. Kroeger
Employees109
Trading Info
Current Price$27.02
Market Cap$21.33M
52-Week Range12.24-21.76
Beta-0.83
ETFNo
ADRNo
CUSIP56565P103
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message